22.68% of the same period of previous year). The profit margin increased from the same period of previous year mainly because the significant growth in revenue. Due to large portion of fixed costs, the

-year performance which has already factored into the Company’s annual growth forecast. Meanwhile, we already have seen signs of improvement in overall advertising sentiment in upcoming November and

its overseas subsidiaries’ operation as well as continuing marketing and managing expense to support existing customers despite of reduced in sales growth as compared. 4. Financial Cost For the third

/2017 (for the equity holders of the Company) was THB 36.65 million, an increase of THB 8.85 million or of 31.83% from the same period last year (Q3/2017 : THB 27.80 million). The Growth in revenues and

-47.86 million, Baht - 50.16 million and Baht -29.12 million in Q1, Q2 and Q3 2017 respectively. Considering the sustainable growth, the company is in the process of launching the new business concept with

the main trading currency of the company), resulting in the company recognized revenue from sales of foreign currency decreased For domestic market, revenue from sales increase lightly due to growth of

Baht or 22.68% due to overall growth of the market. The company recorded domestic sales of 687.94 million Baht which increased from the same quarter last year totaling 162.91 million Baht or 31.03

, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

expenses in proportional to sale decreased from sales growth. Please be informed accordingly Sincerely yours Panjawattana Plastic PCL. 28 Moo 2, Tumbol Chaimongkol, Amphur Muang, Samutsakhon 74000

period of last year by Baht 44.2 million or 12.9%. The major reason for the incremental is from same store sale growth at 10.5% and new branches opened during the year 2018 at 6.8%. Which during the period